{"id":184,"date":"2026-04-11T01:40:25","date_gmt":"2026-04-11T01:40:25","guid":{"rendered":"https:\/\/huavi.pe\/blog\/the-new-york-timess-medvi-profile-under-fire-for-omitting-crucial-information\/"},"modified":"2026-04-11T01:40:25","modified_gmt":"2026-04-11T01:40:25","slug":"the-new-york-timess-medvi-profile-under-fire-for-omitting-crucial-information","status":"publish","type":"post","link":"https:\/\/huavi.pe\/blog\/the-new-york-timess-medvi-profile-under-fire-for-omitting-crucial-information\/","title":{"rendered":"The New York Times&#8217;s Medvi Profile Under Fire for Omitting Crucial Information"},"content":{"rendered":"<p><div style=\"margin: 35px 0; text-align: center;\">\r\n        <script type=\"text\/javascript\">atOptions = {\"key\":\"2d383bfb6047810e1afc5176a93a6e27\",\"format\":\"iframe\",\"height\":90,\"width\":728,\"params\":{}};<\/script>\r\n        <script type=\"text\/javascript\" src=\"https:\/\/www.highperformanceformat.com\/2d383bfb6047810e1afc5176a93a6e27\/invoke.js\"><\/script>\r\n    <\/div>The New York Times recently published a glowing profile of Medvi, an AI-powered startup that operates in the telehealth and compounding pharmacy sectors. The article hailed Medvi as a revolutionary success story, claiming it was on track to surpass one billion dollars in sales. However, this narrative quickly came under scrutiny after readers pointed out significant omissions from the piece. Notably, the article failed to mention crucial details about Medvi&#8217;s regulatory violations, including an FDA warning letter for alleged false and misleading marketing content, as well as its entanglement in multiple legal actions, including a class action lawsuit against the company for violating California&#8217;s spam laws.  The New York Times has since issued an editor&#8217;s note acknowledging these omissions and revising the article to include the missing information. The update states that the company should have included this crucial context to provide readers with a more complete picture of the scrutiny surrounding Medvi.<div style=\"margin: 35px 0; text-align: center;\">\r\n        <script type=\"text\/javascript\">atOptions = {\"key\":\"2d383bfb6047810e1afc5176a93a6e27\",\"format\":\"iframe\",\"height\":90,\"width\":728,\"params\":{}};<\/script>\r\n        <script type=\"text\/javascript\" src=\"https:\/\/www.highperformanceformat.com\/2d383bfb6047810e1afc5176a93a6e27\/invoke.js\"><\/script>\r\n    <\/div><\/p>\n<div style=\"text-align: center; margin: 35px 0;\"><a href=\"https:\/\/www.profitablecpmratenetwork.com\/p4sabm91d?key=88da7d0446f20952699e10bf89600177\" target=\"_blank\" style=\"background: var(--accent); color: #fff; padding: 14px 28px; border-radius: 50px; text-decoration: none; font-weight: 700; font-size: 0.85rem; display: inline-block; box-shadow: 0 4px 15px rgba(0,85,255,0.2);\">Descubrir contenido premium ahora<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>The New York Times recently published a glowing profile of Medvi, an AI-powered startup that operates in the telehealth and compounding pharmacy sectors. The article hailed Medvi as a revolutionary success story, claiming it was on track to surpass one billion dollars in sales. However, this narrative quickly came under scrutiny after readers pointed out [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":185,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[256],"tags":[271,274,273,272,270,166],"class_list":["post-184","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-disrupcion","tag-ai","tag-fda","tag-marketing","tag-telehealth","tag-medvi","tag-global"],"_links":{"self":[{"href":"https:\/\/huavi.pe\/blog\/wp-json\/wp\/v2\/posts\/184","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/huavi.pe\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/huavi.pe\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/huavi.pe\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/huavi.pe\/blog\/wp-json\/wp\/v2\/comments?post=184"}],"version-history":[{"count":0,"href":"https:\/\/huavi.pe\/blog\/wp-json\/wp\/v2\/posts\/184\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/huavi.pe\/blog\/wp-json\/wp\/v2\/media\/185"}],"wp:attachment":[{"href":"https:\/\/huavi.pe\/blog\/wp-json\/wp\/v2\/media?parent=184"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/huavi.pe\/blog\/wp-json\/wp\/v2\/categories?post=184"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/huavi.pe\/blog\/wp-json\/wp\/v2\/tags?post=184"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}